What Esperion Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 10 |
| Total trades | 0 | 28 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 2,945,003 |
| Disposed | 0 | 4,871,864 |
| Net activity | +0 | −1,926,861 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Hoffman Robert | Director | Jul 13 | Disposition to Issuer · D | −85,153 | — | — | 0 |
| Halladay Benjamin | Chief Financial Officer | Jul 13 | Disposition to Issuer · D | −705,410 | — | — | 0 |
| Harlow John B. Jr. | Chief Commercial Officer | Jul 13 | Disposition to Issuer · D | −424,536 | — | — | 0 |
| Koenig Sheldon L. | President and CEO | Jul 13 | Disposition to Issuer · D | −2,121,094 | — | — | 0 |
| Looker Benjamin | Chief Legal Officer | Jul 13 | Disposition to Issuer · D | −667,524 | — | — | 0 |
| Thompson John Craig | Director | Jul 13 | Disposition to Issuer · D | −79,873 | — | — | 0 |
| Carroll J Martin | Director | Jul 13 | Disposition to Issuer · D | −177,523 | — | — | 0 |
| Shepard Jay | Director | Jul 13 | Disposition to Issuer · D | −164,472 | — | — | 0 |
| Fischer Seth H.z. | Director | Jul 13 | Disposition to Issuer · D | −141,023 | — | — | 0 |
| Halladay Benjamin | Chief Financial Officer | Jun 17 | Sale for tax withholding · S | −10,773 | $3.16 | −$34K | 702,829 |
| Koenig Sheldon L. | President and CEO | Jun 17 | Sale for tax withholding · S | −53,588 | $3.16 | −$169K | 2,119,111 |
| Looker Benjamin | Chief Legal Officer | Jun 17 | Sale for tax withholding · S | −11,824 | $3.16 | −$37.3K | 667,524 |
| Hoffman Robert | Director | May 28 | Grant / award · A | +79,873 | — | — | 85,153 |
| Carroll J Martin | Director | May 28 | Grant / award · A | +79,873 | — | — | 177,523 |
| Fischer Seth H.z. | Director | May 28 | Grant / award · A | +79,873 | — | — | 141,023 |
| Shepard Jay | Director | May 28 | Grant / award · A | +79,873 | — | — | 164,472 |
| Thompson John Craig | Director | May 28 | Grant / award · A | +79,873 | — | — | 79,873 |
| Halladay Benjamin | Chief Financial Officer | Mar 17 | Sale for tax withholding · S | −6,424 | $2.71 | −$17.4K | 713,602 |
| Koenig Sheldon L. | President and CEO | Mar 17 | Sale for tax withholding · S | −25,578 | $2.72 | −$69.5K | 2,172,699 |
| Looker Benjamin | Chief Legal Officer | Mar 17 | Sale for tax withholding · S | −5,708 | $2.70 | −$15.4K | 679,348 |
Loading...
